Registries, multicentre and genome-wide association studies in hidradenitis suppurativa.
Gregor B E JemecVéronique Del MarmolVincenzo BettoliMatthias AugustinErrol P PrensChristos C ZouboulisPublished in: Experimental dermatology (2022)
The European Hidradenitis Suppurativa Foundation (EHSF) e.V. has taken several initiatives for collaborative studies. They result from the data of the European Registry of Hidradenitis Suppurativa (ERHS) based on the knowledge obtained from the regional Northern countries (HISREG) and Italian (IRHIS) registries and the real-world data generated from claims data from insurance databases. Multicentre studies, such as the Hidradenitis Suppurativa collaborative study of subtypes (HORUS) and the Global Hidradenitis Suppurativa Atlas (GHISA), are planned to provide an ideal complement to the register studies. Most recently, the role of EHSF as a coordinator or key player is being explored in multiple genetic studies, such as a genome-wide association study (GWAS) and the exome sequencing and cellular/molecular profiling project, which will speed up gene and drug discovery in HS.
Keyphrases
- hidradenitis suppurativa
- case control
- quality improvement
- drug discovery
- electronic health record
- big data
- single cell
- genome wide association study
- clinical trial
- copy number
- healthcare
- genome wide
- machine learning
- randomized controlled trial
- genome wide association
- study protocol
- dna methylation
- artificial intelligence
- double blind